This live session includes two focused presentations covering core addiction medicine topics, combining foundational epidemiologic concepts with a deep examination of alcohol-related harm in the United States.
What This Includes • Hour 1: Epidemiology of Substance Use Disorders - Core epidemiologic concepts, including incidence, prevalence, and study design - National surveillance efforts and major datasets, including NESARC, NSDUH, and Monitoring the Future - Key trends in substance use across populations and identification of at-risk groups - Application of epidemiology to public health policy and clinical practice • Hour 2: Alcohol—The World’s Most Destructive Drug - Epidemiology and scale of alcohol use and alcohol use disorder in the U.S. population - Clinical and public health harms of alcohol, including mortality, cancer risk, and comorbid conditions - Mechanisms of alcohol-related toxicity, including carcinogenesis and neurobiologic effects - Current controversies and evolving guidance on alcohol use and health risk
What to Expect • Live, faculty-led instruction delivered in an interactive online format • Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum • Integration of epidemiologic data with real-world clinical and public health applications • Practical insights into substance use trends, risk factors, and treatment implications • Opportunity to learn from expert faculty with extensive experience in addiction medicine education and clinical care
Timothy K. Brennan, MD MPH
Dr. Brennan is Chief of Clinical Services for the Addiction Institute of Mount Sinai and directs the Addiction Medicine Fellowship at the Icahn School of Medicine at Mount Sinai. He also serves as Vice President for Medical and Academic Affairs for the American College of Academic Addiction Medicine. His work focuses on addiction education, pharmacotherapy, and policy, with a particular emphasis on improving care for patients with substance use disorders across health systems.
Edwin Salsitz, MD
Dr. Salsitz is Associate Clinical Professor of Psychiatry at Mount Sinai and a board‑certified addiction medicine physician with more than 35 years of experience. He has been a national leader in addiction education, serving as faculty for numerous ASAM courses and training clinicians across the country in evidence‑based treatment of substance use disorders. His clinical and academic work focuses on the treatment of opioid use disorder, including medication‑based therapies and emerging challenges such as fentanyl. He is widely recognized for his contributions to physician education, mentorship, and advancing best practices in addiction care.
To support a meaningful learning experience and recognize your participation: